Other Issues:
Journal List
|
previous
|
next
|
latest
|
archive
Volume 52(S1); September 2001
Review Articles
Therapeutic drug monitoring: Introduction
Gillian M Shenfield
Br J Clin Pharmacol.
2001 September;
52
(S1)
: 1S.
doi: 10.1046/j.1365-2125.2001.0520s1001.x.
PMCID:
PMC2014628
|
Abstract
|
PDF–32K
|
Therapeutic drug monitoring beyond 2000
Gillian M Shenfield
Br J Clin Pharmacol.
2001 September;
52
(S1)
: 3S–4S.
doi: 10.1046/j.1365-2125.2001.0520s1003.x.
PMCID:
PMC2014625
|
Abstract
|
PDF–49K
|
Best practice in therapeutic drug monitoring
Annette S Gross
Br J Clin Pharmacol.
2001 September;
52
(S1)
: 5S–10S.
doi: 10.1046/j.1365-2125.2001.0520s1005.x.
PMCID:
PMC2014621
|
Abstract
|
PDF–77K
|
Therapeutic drug monitoring – antiepileptic drugs
M J Eadie
Br J Clin Pharmacol.
2001 September;
52
(S1)
: 11S–20S.
doi: 10.1046/j.1365-2125.2001.0520s1011.x.
PMCID:
PMC2014619
|
Abstract
|
PDF–110K
|
Therapeutic drug monitoring: antiarrhythmic drugs
T J Campbell and K M Williams
Br J Clin Pharmacol.
2001 September;
52
(S1)
: 21S–34S.
doi: 10.1046/j.1365-2125.2001.0520s1021.x.
PMCID:
PMC2014627
|
Abstract
|
PDF–142K
|
The therapeutic monitoring of antimicrobial agents
Evan J Begg, Murray L Barclay, and Carl M J Kirkpatrick
Br J Clin Pharmacol.
2001 September;
52
(S1)
: 35S–43S.
doi: 10.1046/j.1365-2125.2001.0520s1035.x.
PMCID:
PMC2014626
|
Abstract
|
PDF–98K
|
Therapeutic drug monitoring of psychotropic medications
Philip B Mitchell
Br J Clin Pharmacol.
2001 September;
52
(S1)
: 45S–54S.
doi: 10.1046/j.1365-2125.2001.0520s1045.x.
PMCID:
PMC2014618
|
Abstract
|
PDF–102K
|
Target concentration intervention: beyond Y2K
Nicholas H G Holford
Br J Clin Pharmacol.
2001 September;
52
(S1)
: 55S–59S.
doi: 10.1046/j.1365-2125.2001.0520s1055.x.
PMCID:
PMC2014624
|
Abstract
|
PDF–75K
|
Immunosuppressant drugs – the role of therapeutic drug monitoring
Atholl Johnston and David W Holt
Br J Clin Pharmacol.
2001 September;
52
(S1)
: 61S–73S.
doi: 10.1046/j.1365-2125.2001.0520s1061.x.
PMCID:
PMC2014623
|
Abstract
|
PDF–139K
|
Therapeutic drug monitoring of cytotoxic drugs
L Lennard
Br J Clin Pharmacol.
2001 September;
52
(S1)
: 75S–87S.
doi: 10.1046/j.1365-2125.2001.0520s1075.x.
PMCID:
PMC2014622
|
Abstract
|
PDF–128K
|
The role of therapeutic drug monitoring in treatment of HIV infection
David J Back, Saye H Khoo, Sara E Gibbons, and Concepta Merry
Br J Clin Pharmacol.
2001 September;
52
(S1)
: 89S–96S.
doi: 10.1046/j.1365-2125.2001.0520s1089.x.
PMCID:
PMC2014620
|
Abstract
|
PDF–160K
|
Therapeutic drug monitoring in drug overdose
Andrew H Dawson and Ian M Whyte
Br J Clin Pharmacol.
2001 September;
52
(S1)
: 97S–102S.
doi: 10.1046/j.1365-2125.2001.0520s1097.x.
PMCID:
PMC2014629
|
Abstract
|
PDF–87K
|
Therapeutic drug monitoring in a developing country: an overview
N J Gogtay, N A Kshirsagar, and S S Dalvi
Br J Clin Pharmacol.
2001 September;
52
(S1)
: 103S–108S.
doi: 10.1046/j.1365-2125.2001.0520s1103.x.
PMCID:
PMC2014617
|
Abstract
|
PDF–82K
|
Other Issues:
Journal List
|
previous
|
next
|
latest
|
archive
